In addition to formal education and extensive research experience in molecular microbiology and microbial pathogenesis, Erin Hill has significant experience in technical and product-based assessments in the context of new product evaluation for pipeline growth and new product launch, as well as for university technologies. Prior to joining the firm, Erin worked as a consultant for pharmaceutical and biotech companies where she conducted market research with key opinion leaders in multiple therapeutic areas, including neurology, ophthalmology, diabetes, rheumatology, gastroenterology, cardiovascular disease, oncology, and pain.